Pharmaceuticals Latin America

Latin America Long-Read Sequencing Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Latin America Long-Read Sequencing Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Latin America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $48.4 Mn Placeholder estimate
Estimate 2025 $60.8 Mn 3.9% of the global market
Projected 2034 $476.6 Mn 683.5% Adds $415.8 Mn over 9 forecast years
CAGR 2025–2034 25.7% Faster than 92% of 180 Pharmaceuticals markets here
Key players 5
  • Latin America is 3.89% of the global market.
  • Among regions, the largest is North America at $801.0 Mn.
  • Fastest growing: Africa at 26.4% a year.
  • Latin America ranks 4th of 6 by size among regions.

Market size projection

Latin America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$415.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Long-Read Sequencing Market market size by year, Latin America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $48.4 Mn — —
2025 (base) $60.8 Mn +$12.4 Mn —
2026 (forecast) $76.5 Mn +$15.6 Mn +25.7%
2027 (forecast) $96.1 Mn +$19.7 Mn +58%
2028 (forecast) $120.8 Mn +$24.7 Mn +98.6%
2029 (forecast) $151.9 Mn +$31.1 Mn +149.7%
2030 (forecast) $190.9 Mn +$39.0 Mn +213.8%
2031 (forecast) $240.0 Mn +$49.1 Mn +294.5%
2032 (forecast) $301.6 Mn +$61.7 Mn +395.8%
2033 (forecast) $379.2 Mn +$77.5 Mn +523.3%
2034 (forecast) $476.6 Mn +$97.4 Mn +683.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.56 Bn
  2. North America $801.0 Mn
  3. US $639.9 Mn
  4. APAC $329.2 Mn
  5. Europe $264.2 Mn
  6. Canada $124.0 Mn
  7. China $122.8 Mn
  8. Japan $103.1 Mn
  9. Latin America (this report) $60.8 Mn
  10. Middle East $58.3 Mn
  11. Germany $48.2 Mn
  12. Italy $41.9 Mn
  13. France $37.3 Mn
  14. UK $36.6 Mn
  15. Brazil $34.9 Mn
  16. Spain $30.7 Mn
  17. India $32.1 Mn
  18. Ecuador $30.3 Mn
  19. Saudi Arabia $28.5 Mn
  20. Africa $21.9 Mn
  21. Mexico $20.0 Mn
  22. New Zealand $17.1 Mn
  23. Russia $16.7 Mn
  24. Australia $16.5 Mn
  25. South Africa $9.4 Mn
  26. UAE $7.1 Mn
  27. Egypt $4.5 Mn
  28. Philippines $3.9 Mn
  29. Malaysia $2.8 Mn
  30. Hong Kong $2.2 Mn
  31. Singapore $1.7 Mn
  32. Thailand $1.7 Mn
  33. Kenya $1.1 Mn

Report snapshot

Latin America Long-Read Sequencing Market Analysis at a glance
Market size, 2025$60.8 Mn placeholder estimate
Forecast, 2034$476.6 Mn placeholder estimate
Growth (CAGR), 2025–203425.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, application and end user (see all)
Key playersPacific Biosciences, Oxford Nanopore Technologies, Illumina, Inc., MGI Tech, Roche (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Latin America Long-Read Sequencing Market Analysis Executive Summary

Long-read sequencing reads long stretches of DNA in one go, finding complex genetic changes that short-read sequencing can miss.

Key segments of the long-Read Sequencing market include technology (Nanopore Sequencing and HiFi Sequencing) and application (Rare Disease, Structural Variants and Infectious Disease).

Bar chart: Latin America Long-Read Sequencing market size, 2024–2034, placeholder estimates. $48.4 Mn in 2024, $60.8 Mn in 2025 and $476.6 Mn in 2034, 25.7% CAGR.
Latin America Long-Read Sequencing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Latin America Long-Read Sequencing Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the long-Read Sequencing market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the long-Read Sequencing market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the long-Read Sequencing market.

Competitive Landscape for Long-Read Sequencing Market in Latin America

The long-Read Sequencing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Long-Read Sequencing Market in Latin America

Long-Read Sequencing in Latin America: rules and payment

In some of the countries we cover here, medicines are approved by ANVISA (Brazil)⁠[1], ARCSA (Ecuador)⁠[2] and COFEPRIS (Mexico)⁠[3]. How care is paid for in some of these countries: the SUS (Brazil)⁠[4]; public care and IESS (Ecuador)⁠[5]; and IMSS, ISSSTE and IMSS-Bienestar (Mexico)⁠[6].

[1] ANVISA. Checked 14 Nov 2026.

[2] ARCSA. Checked 14 Nov 2026.

[3] COFEPRIS. Checked 14 Nov 2026.

[4] CONITEC. Checked 14 Nov 2026.

[5] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.

[6] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for long-Read Sequencing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Latin America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Long-Read Sequencing right now, from free public sources.

Latest research 4,988 papers since 2021 (worldwide)

  1. The hidden burden of structural variants in neurodegenerative and neuromuscular disorders. Scientific reports, 2026
  2. The hidden genome of high-grade serous ovarian carcinoma: repetitive DNA, extrachromosomal DNA, and complex structural variation. Frontiers in molecular biosciences, 2026
  3. Evaluation of full-length 16S rRNA amplicon sequencing using Oxford Nanopore Technologies for diversity surveys of understudied microbiomes. Access microbiology, 2026
  4. Impact of rumen microbiome sample handling and extraction procedures on downstream long-read sequencing. Frontiers in cellular and infection microbiology, 2026
  5. The comprehensive detection of hemoglobinopathy variants via long-read sequencing. Human genomics, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Long-Read Sequencing in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Long-Read Sequencing market in Latin America?
Placeholder estimate: about $60.8 Mn in 2025, rising to about $476.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Long-Read Sequencing market in Latin America growing?
Placeholder estimate: about 25.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Long-Read Sequencing market report cover?
The report splits the market by technology (Nanopore Sequencing, HiFi Sequencing), application (Rare Disease, Structural Variants, Infectious Disease, Agrigenomics) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Long-Read Sequencing market?
Key players include Pacific Biosciences, Oxford Nanopore Technologies, Illumina, Inc., MGI Tech and Roche.
What is driving the Long-Read Sequencing market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the long-Read Sequencing market.
How much research is published on Long-Read Sequencing?
PubMed lists 4,988 papers on Long-Read Sequencing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Long-Read Sequencing in Latin America? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Latin America

See all
Same topic, other categories

Related on genomics

See the topic